Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04014010
Other study ID # 1024251
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2013
Est. completion date December 31, 2017

Study information

Verified date June 2020
Source Nova Scotia Health Authority
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

With population aging and limited resources, strategies to improve outcomes after surgery are ever more important. There is a limited understanding of what ranges of hemodynamic variables under anesthesia are associated with better outcomes. This retrospective cohort study will analyze how hemodynamic variables during surgeries predict mortality, morbidity, Intensive Care Unit admission, length of hospital stay, and hospital readmission. The use of machine learning in a large, broad surgery population dataset could detect new relationships and strategies that may inform current practice, and generate ideas for future research.


Description:

Lay Summary

Introduction: The World Health Organization estimates that 270-360 million operations are performed every year worldwide. Death and complications after surgery are a big challenge. In Canada, out of every 1000 major surgeries, 16 patients die in hospital after surgery. In the United States, for every 1000 operations, 67 patients unexpectedly need life support in the Intensive Care Unit. With population aging and limited resources, strategies to improve health after surgery are ever more important.

Vital signs, such as blood pressure and heart rate, show how the body is doing. Vital signs change during surgery because of patient, surgical, and anesthetic factors. Anesthesiologists can change vital signs with medications. However, medical professionals are only starting to understand which, and what ranges of, vital signs under anesthesia are associated with better health. Machine learning is a tool that can provide new ways to understand data. With better understanding, medical professionals can work to improve outcomes after surgery.

Objective: This study will analyze vital signs during surgeries for their links to death, complications (heart, lung, kidney, brain, infection), Intensive Care Unit admission, length of hospital stay, and hospital readmission. This study will determine which, and what levels of, vital signs may be harmful. The investigators predict that blood pressure, heart rate, oxygen level, carbon dioxide level, and the need for medications to change blood pressure will interact to be associated with death after surgery.

Methods: After obtaining Research Ethics Board approval, the investigators will analyze data from all patients who are at least 45 years old and had an operation (with the exception of heart surgery) with an overnight stay at the Queen Elizabeth II health centre (Halifax, Canada) from January 1, 2013 to December 1, 2017. There are approximately eligible 35,000 patients. The investigators will use machine learning to model the data and test how well our model explains outcomes after surgery.

Significance: The use of machine learning in a large, broad surgery population dataset could detect new relationships and strategies that may inform current practice, and generate ideas for future research. A better understanding of the impact of vital signs during surgeries may unveil methods to improve outcomes and resource allocation after surgery. The results may suggest ways to identify high-risk patients who should be monitored more closely after surgery. If the model performs well, it may motivate other researchers to use machine learning in health data research.

Please see full protocol for details.

May 2020 update (prior to dataset aggregation and analysis)

1. Added secondary outcome (days alive and out of hospital at 30 days postoperatively)

2. Improved hemodynamic variable artifact processing algorithm

3. Added sub-study: machine learning for invasive blood pressure artifact removal algorithm


Recruitment information / eligibility

Status Completed
Enrollment 35000
Est. completion date December 31, 2017
Est. primary completion date December 31, 2017
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility Inclusion Criteria:

- All patients ages = 45 receiving their index (i.e. first) non-cardiac surgery with an overnight stay at the Nova Scotia Health Authority Queen Elizabeth II (QEII) hospitals (Victoria General and Halifax Infirmary) Halifax, Canada, from January 1, 2013 to December 1, 2017.

- For patients who had multiple surgeries, only the first non-cardiac surgery with an overnight stay at QEII will be included to avoid confounding from previous surgical admissions (i.e. one surgical admission per patient).

Exclusion Criteria:

- No intraoperative anesthetic records

- Cardiac surgery patients

- Deceased organ donation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Blood pressure
Systolic Blood Pressure (SBP) Maximum change from preoperative SBP, in a) absolute change (mmHg), and b) relative change (%)(emergency and elective cases analyzed separately) Cumulative duration (minutes) >=20% below preoperative SBP Longest single episode (minutes) below a) 80, b) 90, and c)100 mmHg Cumulative duration (minutes) below a) 80, b) 90, and c)100 mmHg Mean Arterial Pressure (MAP) Maximum change from preoperative MAP, in a) absolute change (mmHg), and b) relative change (%) (emergency and elective cases analyzed separately) Cumulative duration (minutes) >=20% below preoperative MAP Longest single episode (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg Cumulative duration (minutes) below a) 60, b) 65, c) 70, and d) 80mmHg
Heart rate
Maximum change (beats per minute, BPM) from preoperative heart rate (positive and negative) Relative change (%) from preoperative heart rate (positive and negative) Maximum pulse variation (maximum heart rate minus minimum heart rate) Longest single episode (minutes) a) below 60, and b) above 100BPM Cumulative duration (minutes) a) below 60, and b) above 100BPM
Use of hemodynamic medications (i.e. special medications for blood pressure)
Vasopressor/inotrope use (yes vs. no): phenylephrine, norepinephrine, epinephrine, vasopressin, dobutamine, or milrinone Infusion of any vasopressor/inotropes above (yes vs. no) (identified by unit of weight over time) Phenylephrine/ephedrine bolus (yes vs. no) (identified by unit of weight only) Vasodilator use (yes vs. no): labetalol, esmolol, nitroglycerin, nitroprusside Infusion of any vasodilator above (yes vs. no) (identified by unit of weight over time)
Oxygen saturation by pulse oximetry (SpO2)
Longest single episode (minutes) below a) 88, and b) 90% Cumulative duration (minutes) below a) 88, and b) 90%
End-tidal Carbon dioxide (EtCO2)
Longest single episode (minutes) a) below 30, and b) above 45mmHg Cumulative duration (minutes) a) below 30, and b) above 45mmHg

Locations

Country Name City State
n/a

Sponsors (5)

Lead Sponsor Collaborator
Janny Xue Chen Ke Dalhousie University, Harvard University, University of Ottawa, University of Toronto

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality All-cause postoperative mortality (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Any Any complications in terms of cardiac, respiratory, renal, cerebrovascular, delirium, or septic shock (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Cardiac Composite of acute myocardial infarction, cardiac arrest, ventricular tachycardia, congestive heart failure, pulmonary edema, complete heart block, shock excluding septic shock (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Respiratory Composite of pneumonia, pulmonary embolism, acute respiratory failure, respiratory arrest, Mechanical Ventilation >= 96 hours (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Acute Kidney Injury Acute Kidney Injury (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Cerebrovascular Composite of strokes and transient ischemic attacks (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Delirium Delirium (yes/no) 30 days after date of surgery
Secondary In-hospital Morbidity: Septic Shock Septic Shock (yes/no) 30 days after date of surgery
Secondary Postoperative ICU admission ICU admission (yes/no) 30 days after date of surgery
Secondary Prolonged Postoperative Length of Stay (LOS) Greater than vs. less than or equal to Canadian Institute of Health Information Expected Length of Stay (ELOS) as assigned by the Case Mix Grouping 30 days after date of surgery
Secondary Hospital readmission Hospital readmission (yes/no) 30 days after date of surgery
Secondary Intraoperative mortality Intraoperative mortality (yes/no) 30 days after date of surgery
Secondary Days alive and out of hospital at 30 days postoperatively Number of days 30 days after date of surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A